Cargando…
Statins in risk-reduction and treatment of cancer
Statins, which are competitive inhibitors of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, reduce cholesterol blood levels and the risk of developing cardiovascular diseases and their related complications. In addition to this main activity, statins show pleiotropic effects such as antioxidant,...
Autores principales: | Barbalata, Cristina I, Tefas, Lucia R, Achim, Marcela, Tomuta, Ioan, Porfire, Alina S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443827/ https://www.ncbi.nlm.nih.gov/pubmed/32879845 http://dx.doi.org/10.5306/wjco.v11.i8.573 |
Ejemplares similares
-
Salinomycin-Based Drug Delivery Systems: Overcoming the Hurdles in Cancer Therapy
por: Tefas, Lucia Ruxandra, et al.
Publicado: (2021) -
A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA
por: Toma, Ioana, et al.
Publicado: (2022) -
An Electrochemical Strategy for the Simultaneous Detection of Doxorubicin and Simvastatin for Their Potential Use in the Treatment of Cancer
por: Rus, Iulia, et al.
Publicado: (2021) -
Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach
por: Tefas, Lucia Ruxandra, et al.
Publicado: (2017) -
Development of a Curcumin-Loaded Polymeric Microparticulate Oral Drug Delivery System for Colon Targeting by Quality-by-Design Approach
por: Hales, Dana, et al.
Publicado: (2020)